Veterinary Compounding for Myasthenia Gravis
Author(s): Davidson Gigi S
Issue: Sep/Oct 2008 - Veterinary Compounding
View All Articles in Issue
Abstract: Myasthenia gravis is a neuromuscular disease commonly encountered in veterinary medicine. With accurate diagnosis, treatment, and compliant caregivers, the prognosis for remission and a normal life is good. Unfortunately, drugs used to diagnose and treat myasthenia gravis are frequently unavailable due to manufacturer shortages. During these periods, compounding pharmacists can play a valuable role in maintaining a good quality of life for these patients by providing compounded versions of drugs that are commercially unavailable.
Related Keywords: Gigi S. Davidson, BSPh, DIVCP, FSVHP, formulations, myasthenia gravis, muscle disorders, dogs, veterinary medicine, muscle weakness, cats, edrophomium hydrochloride, acetylcholinesterase inhibitor, acetycholine, neurotransmitter, anticholinesterase agents, pyridostigmine bromide, cellulose, methylcellulose, excipients
Related Categories: EXCIPIENTS, FORMULATIONS, VETERINARY, MUSCULOSKELETAL DISORDERS, NEUROLOGY
Download in electronic PDF format for $35